Accueil/Actions/SXTPW

SXTPW

USD

60 Degrees Pharmaceuticals Inc. Warrant

$0.065+0.015 (29.225%)

Prix en Temps Réel

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$0.050

Haut

$0.065

Bas

$0.050

Volume

0.01M

Fondamentaux de l'Entreprise

Statistiques de Trading

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.05Actuel $0.065Haut $0.065

Actualités Connexes

15 oct. 2025 · 11:14

GlobeNewswire

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA)Results obtained using

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

9 oct. 2025 · 11:04

GlobeNewswire

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study

Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competitionA $5K donation from the Company was split between ILADEF and GLA to recognize the winning nameB-FREE, a Phase